Page 100 - AN-4-3
P. 100

Advanced Neurology                                            TG100-115 suppresses glioblastoma cell functions




                         A



















                         B
















            Figure 4. TG100-115 inhibited the migration of U251 cells at different doses for 24 h. (A) Representative images of wound healing. After being scratched
            with a 200 µL pipette tip, U251 cells were treated with TG100-115 at doses of 60, 120, 160 µM or 0.1% DMSO. Then, the images were captured at
            24 h, and the gap closure was analyzed. Scale bar: 150 µm, magnification: 10×. (B) The wound closure of TG100-115 treatment at different doses was
            significantly decreased compared with DMSO.
            Note: Statistical significance determined at **p<0.01 and ***p<0.001 using one-way analysis of variance with subsequent Newman–Keuls test, n ≥ 6.
            Abbreviation: DMSO: Dimethyl sulfoxide.

            light on its potential role in cellular processes associated   115 significantly reduced the viability and proliferation of
            with migration and invasion.                       U251 cells in a dose-dependent manner, with an IC  of
                                                                                                          50
                                                               155.2  µM. In addition, TG100-115 exhibited substantial
            3.7. TG100-115 did not affect the protein expression   inhibitory effects on U251 cell migration and invasion.
            of TRPM7                                           Furthermore, we  found  that the anti-GBM  activities
            Finally, we investigated the impact of TG100-115 treatment   of TG100-115 were involved in PI3K/Akt and cofilin-
            on the protein expression of TRPM7 in U251 cells. Following   dependent signaling. In this study, experiments were
            a 24-h exposure to either DMSO (0.1%) or TG100-115 (150   initially performed using both U87 and U251 glioma cell
            µM), we assessed TRPM7 expression through western   lines, with preliminary data obtained from both models.
            immunoblotting. As shown in  Figure S2, the raw blot   However, due to variability in experimental conditions
            images are provided in Figure S16, TG100-115 exhibited no   and inconsistencies in U87 cell status, only the U251 cell
            significant influence on the protein expression of TRPM7   data have been reported here. Nevertheless, the relevant
            when compared to the control group (19.1 ± 3.8% vs. 20.3 ±   results from U87 cells are included in Figure S3, raw blot
            4.6%, respectively, p>0.05, n = 4). This suggests that TG100-  images are provided in Figure S17. This data demonstrated
            115 did not markedly influence the protein expression of   that TG100-115 significantly reduced U87 cell viability,
            TRPM7 under the conditions examined in U251 cells.  migration, colony formation, and Akt phosphorylation,
                                                               consistent with the findings observed in U251 cells. Thus,
            4. Discussion                                      the results from both cell lines support the conclusion

            This study demonstrates the role of TG100-115 in GBM   that TG100-115 exerts anti-GBM effects via similar
            cell biological functions. Our results showed that TG100-  mechanisms.


            Volume 4 Issue 3 (2025)                         94                           doi: 10.36922/AN025110023
   95   96   97   98   99   100   101   102   103   104   105